Eligibility, any sex, with Ventricular Dysfunction or Pericardial Effusion. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Patients Detected With Ventricular Dysfunction, Pericardial Effusion, Valvular Disorders, Septal Disorders, and Coronary Anomalies.Primary· Day 1
Comparison of diagnostic ability of portable hand-held cardiac ultrasound with standard transthoracic echocardiography
normal anatomy
Group
Value
95% CI
Standard Transthoracic Echocardiogram Intervention
13
Hand Held Echocardiography
13
minor cardiac abnormality
Group
Value
95% CI
Standard Transthoracic Echocardiogram Intervention
9
Hand Held Echocardiography
4
major cardiac abnormality
Group
Value
95% CI
Standard Transthoracic Echocardiogram Intervention
25
Hand Held Echocardiography
23
Sponsor's own description
To compare the images from standard cardiac ultrasound with images from a small hand-held device; to find out more about the feasibility and accuracy of a small hand-held ultrasound device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 16 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03887286.